Identification of aminopiperidine benzamides as MCHr1 antagonists
摘要:
The identification of a novel series of benzamide-containing MCHr1 antagonists is described. Compound 22 displayed moderate efficacy in a diet induced obesity mice model. (c) 2005 Published by Elsevier Ltd.
Identification of aminopiperidine benzamides as MCHr1 antagonists
摘要:
The identification of a novel series of benzamide-containing MCHr1 antagonists is described. Compound 22 displayed moderate efficacy in a diet induced obesity mice model. (c) 2005 Published by Elsevier Ltd.
Discovery and Characterization of Aminopiperidinecoumarin Melanin Concentrating Hormone Receptor 1 Antagonists
作者:Philip R. Kym、Rajesh Iyengar、Andrew J. Souers、John K. Lynch、Andrew S. Judd、Ju Gao、Jennifer Freeman、Mathew Mulhern、Gang Zhao、Anil Vasudevan、Dariusz Wodka、Christopher Blackburn、Jim Brown、Jennifer Lee Che、Courtney Cullis、Su Jen Lai、Matthew J. LaMarche、Tom Marsilje、Jon Roses、Todd Sells、Brad Geddes、Elizabeth Govek、Michael Patane、Dennis Fry、Brian D. Dayton、Sevan Brodjian、Doug Falls、Michael Brune、Eugene Bush、Robin Shapiro、Victoria Knourek-Segel、Thomas Fey、Cathleen McDowell、Glenn A. Reinhart、Lee C. Preusser、Kennan Marsh、Lisa Hernandez、Hing L. Sham、Christine A. Collins
DOI:10.1021/jm050598r
日期:2005.9.1
4-(1-Benzo[1,3]dioxol-5-ylmethylpiperidine-4-ylmethyl)-6-chlorochromen-2-one (7) is a potent, orally bioavailable melanin concentrating hormone receptor 1 (MCHr1) antagonist that causes dose-dependent weight loss in diet-induced obese mice. Further evaluation of 7 in an anesthetized dog model of cardiovascular safety revealed adverse hemodynamic effects at a plasma concentration comparable to the minimally effective therapeutic concentration. These results highlight the need for scrutiny of the cardiovascular safety profile of MCHr1 antagonists.